Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Neoplasms 1Advanced Cancer 1

Interventions

Nivolumab 6Ipilimumab 2Gemcitabine 2zaleplon 1temsirolimus 1relatlimab 1regorafenib 1olaparib 1linrodostat 1Vorinostat 1Trastuzumab 1Standard of Care 1Sirolimus 1Rehabilitation 1Psychotherapy 1Paclitaxel 1Oxaliplatin 1Niacin 1IFL protocol 1Health Services Needs and Demand 1Everolimus 1Clinical Trials, Phase IV as Topic 1Cisplatin 1Capecitabine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Advanced Cancer × zaleplon × 1 year × Clear all
NCT07393529 2026-04-15

SONATA 2

University of Rochester

Phase NA Recruiting
70 enrolled

Advanced Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡